Who are the TOP competitors of Dolby Laboratories Inc. (NYSE:DLB)?

Dolby Laboratories Inc. (NYSE:DLB) closed the previous session at $63.30, up by 0.84 or 1.34% higher on its price over the last trading period. Shares of the company have traded -0.31% down in the last 5 days, with the price reaching as high as $63.49 since 10/15/19. The stock however has recovered +3.60% since hitting 5-day low of $61.10. The DLB stock is -3.93% lower than the $65.89 top value it marked over a period of month. Dolby Laboratories Inc. (NYSE:DLB) has a 52-week price range of $56.09- $71.77. The stock is 2.36% up year-to-date. Can DLB go on to record further gains or will the drop below $62.46 be witnessed again in coming days?

In comparison, let’s see recent movement of other stocks the recent users of Yahoo Finance’s stock information-accessing system have also looked at before they searched Dolby Laboratories Inc. (DLB). Shares of Shutterstock Inc. (NYSE:SSTK) changed $1.02 or a gain of 2.96% to close at $35.45, while the stock of IMAX Corporation (NYSE:IMAX) dropped nearly -0.63% in the last session to close at price of $20.55. Eros International Plc (NYSE:EROS) advanced $0.17 in value, or 13.08% to see deals exchanging hands at $1.47 in the last period. Cinedigm Corp. (NASDAQ:CIDM) gained $0.01 or about 0.91 to see its shares trade at $0.92.

What do analysts say about the Dolby Laboratories Inc. (NYSE:DLB) stock in terms of estimates, with 5 ratings?. The analysts’ current recommendation for the stock is a Buy, versus Overweight a month ago and a Overweight rating 3-month ago. The total number of analysts who have rated DLB as a buy is 4, with just 0 of 5 recommending it as a Sell. 5 analysts of the 0 rated it as underweight; while 1 advised Hold and a further 0 say the stock is Overweight.

Lets us now look at some key statistics for the company and see what they tell us about its books. Dolby Laboratories Inc. has a market valuation of $6.23 billion, with its Enterprise Value at $5.55 billion. The enterprise value (EV) is -12.25% off Dolby Laboratories Inc.’s market cap. Shares traded in the last session stood at 250489 while the average trading volume is 405.08K. Insiders own 0.40% of the shares institutions own 94.00% as outstanding shares currently stand at 98.40 million. When we look at the 20-day simple moving average, DLB is 0.38%, while that moves to 2.46% over its 50-day SMA and the SMA200 is -0.23%.

When we look at the consensus estimate for DLB shares, we find that Wall Street analysts have given the average target price of $74.75. The earnings estimate for the current quarter is 0.48, lower than the 0.65 expected for the next quarter. The stock has earnings per share estimate ranging between a low of 0.47 and a high of 0.51, with the coefficient variance at 4.12. For this fiscal year, the estimate climbs to 5.00 versus the 5.00 expected for the next year. DLB has current-year EPS range between a low of 2.48 and a high of 2.52, with the coefficient variance at 0.84.

The stock’s trailing per-earning (P/E) is $26.39 while the forward P/E is $22.04. The company’s trailing 12-month price-to-sales ratio is 5.16. In terms of profitability, the company has a profit margin of 21.60% and a trailing 12-month (ttm) operating margin of 20.10%. The company’s gross margin is 87.80%. DLB is one of the hottest stocks right now and that shows in its potential upside on returns with a 9.20% ROA for the last 12 months and a return on equity (ROE) of 11.20% over the same period.

For the fiscal quarter ending 9/29/2018, Dolby Laboratories Inc. had revenue of $297.55M. The earnings per share for the most recent quarter were 0.47. The EPS for the recent quarter beat consensus estimates by $0.17 per share after analysts had predicted $0.3. EPS posted in 3 out of the last 4 quarters have beaten analysts’ estimates. The company’s total fiscal year 2019 revenue is $1.17 billion and an EPS of $2.40, while the annualized dividend $0.76. Current yields for investors stand at 1.20% and the next payment date is 10/25/2019.

The investor community is excited about the DLB stock, with the Barchart 16% Sell showing that the stock could be headed for a massive downtrend. The stock’s 1-month chart already shows that the stock is -1.81% down and -2.90% lower in the last 3 months. Its 12-month performance is showing the stock trending lower by -7.37%. There might be a slight pullback as $63.67 is the first resistance point and if crossed $64.04 should come in play as the second resistance level. DLB could see support around 62.76 and will later test the 62.21 support.